The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

RMD FINANCIAL STATEMENTS

Resmed Inc — balance sheet, income statement and cash flow trends

RMDResmed Inc

🇦🇺 Australia · AU · Healthcare · Medical Instruments & Supplies

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
02 B4 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue5.6 B $Gross Profit3.4 B $ · 60%Operating Income1.9 B $ · 34%Pre-tax Income1.9 B $ · 34%Net Income to Owners1.5 B $ · 27%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue5.6 B $+9.4%
Gross Profit3.4 B $+11.4%
Operating Income1.9 B $+12.7%
EBITDA2.1 B $+11.1%
Net Income to Owners1.5 B $+7.8%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
02.5 B5 B7.5 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets9 B
  • Equity6.6 B $73%
  • Current Liabilities1.4 B $16%
  • Long-term Liabilities985 M $11%

Key Figures

YoY change
Total Assets9 B $+9.6%
Total Liabilities2.4 B $+7.8%
Total Equity6.6 B $+10.3%
Cash & ST Investments1.5 B $+21.4%
Total Debt825.6 M $-3.1%
Net Debt-643 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
01 B2 B202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
0500 M1 B1.5 B1.8 B $Operating-550.1 M $Investing-1 B $Financing245.5 M $Net Change

Key Figures

YoY change
Operating Cash Flow1.8 B $+2.6%
Capital Expenditures155.4 M $+61.8%
Free Cash Flow1.6 B $-0.9%
Dividends Paid347.2 M $+11.7%

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on RMD

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.